1CSIR – Plant Genetic Resources Research Institute, Post Office Box 7, Bunso, Ghana
2CIRAD, AGAP institute, Avenue Agropolis, BP 5035, 34398 Montpellier, France.
3CSIR – Crops Resources Research Institute, P. O Box 3785 Fumesua, Kumasi - Ghana
4Ho Technical University, Ho, Ghana
Bissah.M.N, CSIR-Plant Genetic Resources Research Institute, Post Office Box 7, Bunso, Ghana
Bissah. M.N., Et,All,.Overview of CRISPR-Cas9 technologies and its application in crop improvement. Int. J. Genet. Genom. Sci. Vol.2.Iss.(1).(2023). DOI:10.58489/2836-2306/007
© 2023 Bissah. M.N, this is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Genome editing, CRISPR Cas9, Applications, Crop improvement
Genome editing offers a range of solutions for more efficient development of crops that are productive, adapted to stresses, climate-resilient, and less dependent on agro-inputs. Clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein (Cas9) technology is the current dominant tool used for genome editing. Originally, a Cas9 nuclease was employed to induce a double-strand break in its target site, causing the deletion of a few base pairs, inversion, and gene integration to deliver desired changes in organisms. Aside from the primary nuclease activity (knock-in/out), a Base editor system, Gene priming and Cargo chauffeuring activities have been reported to deliver functionalities to specific regions in the DNA such as regulating transcription and fluorescence DNA for visualizing and understanding biological systems. Limitations of the scope of Cas9 activity were also eliminated by the recent development of more Cas9 orthologues (Cpf1-RR and Cpf1-RVR). Cas9 together with the advent of novel base editing tools that enable precise genome modifications and DNA-free genome editing via ribonucleoproteins, demonstrates significant promise in the development of future crop improvement strategies. However, large-scale adoption of CRISPR/CAS will require optimizing strategies while accounting for costs, ease of implementation, and potential impacts on production gains. This review focuses on CRISPR application in plants, advances in CRISPR technology, regulations that may disadvantage scientists, resources for the smooth application of CRISPR and the preparedness of Africa to benefit from CRISPR technology.
Mutagenesis conferring genome changes in organisms may either turn off (Gene knockouts) or on (Gene knock-in) the function of genes in target regions. This results from a disruption in the synthesis of essential amino acids relevant in diverse metabolic pathways. Genetic mutants are essential for elucidating the genetic and molecular controls of many important biological mechanisms (Fang et al., 2018; Li et al., 2018; Ding et al., 2016; Matsumoto, 2005). The use of mutant-induced genetic variations in plant breeding commenced in the 1960s when radiation and chemical mutagenesis were developed to select favorable genetic combinations. Alterations in the sequence of the Deoxyribonucleic acid (DNA) (single or double-stranded) of organisms are critical for gene disruption (Durland & Ahmadian-Moghadam, 2021; Chaud- hary et al., 2019). At present, gene transfer and elimination can be achieved through conventional crosses, mutagenesis or through biotechnological approaches like genome editing(Sedlar, 2020; Cardi, 2016). Mutant libraries of several model plants have been generated by physical, chemical, or insertion (T-DNA/transposon insertion) mutagenesis and, more recently,by genome editing techniques (Lu et al., 2017; Meng et al. 2017). Traditional mutagenesis approaches often generate random mutations in the host genome, which could often cause deleterious effects that may not be intended and have many drawbacks including large screening populations to identify desired variants (Mohanta et al., 2017; Sikora et al., 2012; El-Gewely et al., 2005). Since the late 2000s four families of engineered and programmable nucleases including Me- ga-Nucleases, Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector nucleases (TALEN) and the Clustered Regularly Inter-Spaced Short Palindromic Repeats (CRIS- PR) Cas9 changed mutagenesis from random events to tar- geted modification of genomes (Mohanta et al., 2017; Gaj et al., 2016; Liang et al., 2014). These developments have limited mutations to specified regions of the genome, which, have helped decipher the function of genes more accurately. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9-associated protein technology is the cur- rent dominant genome editing tool used to manipulate and change the DNA of organisms (Ahmad et al., 2020;Wada et al., 2020;Tripathi et al., 2020;Li et al., 2017; Haeussler and Concordet, 2016). The CRISPR technology mimics the sur- veillance system performed by immune memory in bacteria that enables it to recognize and degrade foreign nucleic ac- ids (Koonin et al., 2017; Doudna and Charpentier, 2014;Fin- eran and Charpentier, 2012). The engineered CRISPR-Cas9 system relies on single guide RNA (sgRNA), a small non-coding RNA composed of a crR- NA homologous to a genome target region and a tracrRNA that binds to CAS9. Target sites are generally located in the exon regions of an open reading frame in order to induce effective frameshift mutations (Jinek et al., 2012; Biswas et al., 2019).The target region of CRISPR sgRNA is usually 3 bp upstream of the NGG Proto-spacer Adjacent Motif (PAM) (Meng et al., 2017). The Cas9 has a bi-lobed architecture, with a large globu- lar recognition lobe (REC) and a small nuclease lobe (NUC) with two nuclease domains, RuvC and HNH, used to edit the DNA at the right position (Li et al., 2018; Endo et al., 2018;Lei et al., 2014;Voytas, 2013) The CRISPR/Cas9 system can be delivered to targeted cells either indirectly by biological transfer (Agrobacterium tumefaciens) or directly by microprojectile bombardment of cul- tured tissues, electroporation, or chemical treatment (polyethylene glycol—PEG) of protoplast suspensions. Alternatively, it can be delivered as ribonucleoprotein complexes in bom- barded tissues or protoplasts (Sharma et al., 2020;Liang et al., 2019;Murovec et al., 2018; Liang et al, 2017; Ding et al., 2016; Doench et al., 2016; Zhang et al., 2016;Krenek et al., 2015;Woo et al., 2015; Mao et al., 2013). However, CRISPR applications in plants have largely depended on Agrobacterium-mediated T-DNA transformation, which, is limited to a narrow range of genotypes within a species. The traditional CRISPR genome editing process relies on the double-strand break (DSB) repair capacity of recipient cell types, the promoter under which the Cas9/gRNA is expressed and the regeneration efficiency of the crop (Ding et al., 2016). The DNA breaks caused by the nuclease are generally repaired by non-homologous end joining (NHEJ) eventually causing deletion and/or insertion of nucleotide(s) or, when a DNA repair template with homology regions with the target site is provided, homology-directed repair (HDR) (Lieber, 2010) (Figure 1). In the NHEJ approach, the cell repair mechanism attempts to rejoin the cut ends but loses or induces a few bases in the process: a situation that can result in gene alterations due to frameshift mutations. In the HDR situation, donor repair templates are supplied, and the DSB repair may results in the integration of the donor sequence to allow targeted modification of genes by small to large nucleotide replacement or insertions, but its efficiency remains low in flowering plants (Endo et al., 2018; Li et al., 2018; Shibata, 2017; Jiang et al., 2017;Zhang et al., 2017;Gaj et al., 2016; San Filippo et al., 2008).

Figure 1: Repair of double strand break in DNA (Adapted from Wu et al., 2020) Advances in CRISPR-Cas9 technology development and applications The original CRISPR-Cas9 protein uses a combination of an enzyme that cuts DNA (Cas9, a nuclease) and a guiding piece of genetic material (guide RNA) that specifies the location in the genome to be targeted. The application scope of CRISPR – Cas9 was expanded with the use of new CAS9 variants or CAS proteins with different specificities, notably the PAM, base editing, prime editing and simultaneously targeted mutations (multiplexing) (Wu et al., 2020; Wang et al., 2018; Ding et al., 2016). Recently, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas12a nuclease (Cpf1), dCas9 transcriptional regulators, base editors, PRIME editors, and RNA editing tools are widely used in basic research (Wu et al., 2020; Ai, et al., 2022).
The original CRISPR-Cas9 technology is based on the commonly used Streptococcus pyogenes Cas9 system which recognizes only Proto-spacer adjacent motif (PAM) = NGG. Alternative genome editing technologies including CRISPR Prevotella and Francisella 1 (Cpf1) or Cas12a have opened up CRISPR editing to additional areas of the genome (Shmakov et al.,2017., Gao et al., 2017). The Cas9 and Cpf1 differ in the structural organization as the Cpf1 protein is smaller, use of a shorter guide as the matu- ration of crRNA by Cpf1 does not require the assistance of trans-activating crRNA (tracrRNA). Whereas Cas9 cleaves the DNA close to the PAM site with blunt ends, Cpf1 cleaves distal to the PAM site and produces staggered ends, which offer the opportunity for further modification at the same would also facilitate HDR. The Cpf1 recognizes TTTV as well as TTTT PAM sites increasing the target range for ge- nome editing for the Cas9 tool (Jiang et al., 2017; Ding et al., 2016; Kleinstiver et al., 2015). The Cas9 and Cas12a both cut DNA, while the Cas13 family has been shown to target RNA (Ai et al. 2022; Tang et al. 2021; Yangs et al. 2019)
Recently, new and more powerful techniques to edit genes have been developed based on the disabled activity of the Cas9 nuclease. When the nuclease activity of the Cas9 protein is disabled, it is referred to as dead (dCas9). The dead Cas9 can be fused to transcription activators, epigenetic modifiers and Fluorescence-labeled Epitope-tagged to modulate transcription reporter gene function (Veillet et al., 2020; Li et al., 2016; Kleinstiver et al., 2015; Fu et al., Multiplex genome editing). Another important development in the CRISPR-Cas9 technology is the ability to effectively express multiple sgRNAs for simultaneous editing of two or more 2014; Mercer et al., 2012). New technologies have been developed for gene activation, replacement, and insertion to satisfy various demands of genome editing for functional genomic studies, which eliminate the necessary injury due to the double-strand break (DSB) associated with traditional Cas9 technology.
Is the conversion of one base or base pair into another (e.g., A:T to G:C, C:G to T:A) or the introduction of point mutations at specific sites which permits the recoding of the DNA sequences (Li et al., 2021; Veillet et al., 2020; Li et al., 2018; Kim et al., 2017; Zong et al., 2017). The Adenine (Adenine - Guanine) and cytidine (cytosine-uracil-thiamine) base editors introduce mutations that largely do not disrupt the function of genes (Kim et al., 2017). The cytidine deaminase enzyme removes an amino group from cytosine, converting it to uracil, resulting in a U-G mismatch, which gets resolved via DNA repair pathways to form U-A base pairs. Subsequently, a T gets incorporated into the newly synthesized strand, forming T-A base pairs. This results in C-G to T-A conversion in a programmable manner. Unlike cytidine deaminases, adenine DNA deaminases do not occur in nature. In 2017, David Liu and the group developed ABEs by using Escherichia coli TadA (E. coli TadA) through extensive protein engineering and directed evolution. Escherichia coli TadA is a tRNA adenine deaminase that converts adenine to inosine in the single-stranded anticodon loop of tRNA Arg. It shares homology with the APOBEC enzyme. The procedure involves the conversion of Cas9 nuclease to nickase followed by the fusion of the nickase with the deaminase enzyme (either cytidine deaminase or engineered adenine deaminase for C-G to A-T and A- T to C-G conversions respectively) (Veillet et al., 2020). The base editing technique permits the conversion of alleles by base change, the creation of premature stop codon for knockout, and the creation of new alleles of genes that do not exist in nature and has the advantage of overcoming the long procedure of introgressing new alleles. For instance, the acetolactate synthase (ALS) gene in tomatoes has been edited using Agrobacterium-mediated transformation with a Cytidine base editor changing amino acids essential for the protein to be targeted by the chlorsulfuron herbicide (Veillet et al., 2019). The authors reported the production of chlorsulfuron-tolerant plants with up to 71 genes (Wang et al., 2018;Ma et al., 2015; Lowder, et al., 2015; Cong et al., 2013; Kurata, et al., 2018; Li et al., 2018; Wang et al., 2017). Multiplexing thus addresses the extremely time-consuming and laborious bottleneck of conventional cross-breeding methods for pyramiding multiple QTLs (Abdelraman et al., 2021). In China, a CRISPR/Cas9-mediated multiplex genome editing system was used to simultaneously mutate three major genes in rice which negatively regulated grain weight including Grain Width 2 (GW2), Grain Width 5 (GW5) and Thousand-Grain Weight 6 (TGW6)(Dai et al., 2016). All three genes generated mutants (gw5tgw6 and gw2gw5tgw6) which showed notably larger grain sizes than that of the wild-type (Dai et al., 2016). In hexaploid bread wheat, CRISPR-Cas9 has been used to modify multiple alleles to confer heritable resistance to powdery mildew (Wang et al. 2014b, Wang et al. 2018).
An important feature of the agricultural application of CRISPR-Cas9 technology is the delivery of nontransgenic traits in crops. In seed-propagated crops, the CRISPR/Cas9 transgene can be easily eliminated through Mendelian segregation in progenies. This process alone distinguishes the technique from the class of GMOs and hence absolves CRISPR edits from rigorous testing regimes. The transformation of protoplasts followed by plant regeneration allows either the delivery of a ribonucleoprotein complex or the transient expression of delivered plasmid DNA without DNA integration into the host genome. Such methods are particularly useful for vegetatively propagated crops. Woo et al. (2015) have optimized CRISPR/Cas9 ribonucleoproteins (RNPs) to completely avoid transgene integration. Veillet et al. (2019) reported 12.9% and 10 Applications of CRISPR technologies in crop improvement. 3.1 CRISPR-Cas9 genome editing methods have been exploited in several spheres of research including breeding and development of agricultural crops, animals, and human health genetic applications (Ahmad et al., 2020; Tripathi et al., 2020; Wada et al., 2020; Bao et al., 2019; Ding et al., 2016). In agriculture, CRISPR-Cas9 has been applied to modify and understand the functions of genes controlling major agronomic, nutritional and economic traits in a vast array of crops to achieve improved yield performance, enhanced nutritional quality (biofortification), and biotic and abiotic stress tolerance (Johnsson et al., 2019; Romero and Gatica-Arias, 2019; Mishra and Zhao, 2018; Mohanta et al., 2017; Zhang et al., 2017). There are several efforts of gene function analysis in important crops including bananas, cassava, maize, millet rice, sorghum, soybeans, tobacco, and tomatoes. Table 1 shows some of the current applications of CRISPR/Cas9 systems in crops are for studying gene function, improving agricultural traits, creating male-sterility mutants, and inducing haploids. The role of genomics in plant research and sustainable crop production is imminent, and it will become even more crucial in the future. Two key applications of CRISPR that will revolutionize agriculture more than the green revolution are the fixing of hybrids and the enhancing of diversity to improve adaptation.
Promoting apomixis for hybrid vigor preservation through the CRISPR/Cas9 editing